IDT Opens New Synthetic Biology Facility in Coralville, IA

Integrated DNA Technologies (IDT) Expands Synthetic Biology Footprint with New Facility in Iowa

Integrated DNA Technologies (IDT) is making headlines in the synthetic biology industry with the recent opening of its new 25,000 square-foot site in Coralville, IA. This expansion doubles IDT’s synthetic biology footprint and sets the stage for further advancements in gene synthesis.

The newly constructed two-story building, solely dedicated to the manufacturing of IDT synthetic biology products, offers ample space for growth and innovation in the field. Demaris Mills, President of IDT, expressed enthusiasm about the new facility, emphasizing its significant capacity addition and potential for future growth in their synthetic biology product portfolio.

With a focus on enhancing its gene synthesis offerings, IDT is gearing up to introduce new product enhancements, including a rapid gene synthesis offering anticipated to launch in late Q2. This investment underscores IDT’s commitment to meeting the demands of the rapidly expanding global DNA synthesis market and supporting related drug development activities.

The state-of-the-art facility features advanced lab spaces, as well as office and conference rooms, amenities, and dedicated support resources. Designed for efficiency and sustainability, the facility includes enhanced cold storage, lean manufacturing processes, and energy-efficient lighting and automation systems.

This marks the second facility completion for IDT in the past year, following the establishment of its Therapeutic Oligonucleotide Manufacturing facility in Iowa in late 2023. As a leading provider of genomics solutions, IDT continues to push boundaries and drive innovation in the synthetic biology space, solidifying their position as a key player in the industry.

For more information about IDT and their latest developments, visit www.idtdna.com and follow the company on social media platforms.